SureTrader SPDR Advertisement
Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

CTIX RSS Feed
Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator BigKahuna, BooDog, KarinCA, noretreat, TOB, starbuxsux
Search This Board:
Last Post: 8/30/2015 5:30:42 PM - Followers: 644 - Board type: Free - Posts Today: 26

Cellceutix Corporation (CTIX) 
 

 

http://cellceutix.com/
 
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
Email:  info@cellceutix.com
 
CIK:  0001355250
 
Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin is currently in a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. In the laboratory Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is planning a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention and treatment of Oral Mucositis. Brilacidin-OM, a defensin mimetic compound, has shown in the laboratory to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol is presently in a bioequivalence crossover clinical trial in Miami, FL. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s key antibiotic, Brilacidin, is in a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Brilacidin has the potential to be a single-dose therapy or a dosing regimen that is shorter than currently marketed antibiotics for multi-drug resistant bacteria (Superbugs). Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.

 

Management:   http://cellceutix.com/team/
The above link is kept updated.
http://www.zoominfo.com/p/Daniel-Jorgensen/1064701588
 

 
Ongoing Human Trials:  http://clinicaltrials.gov/ct2/results?term=Cellceutix+Pharmaceuticals&Search=Search
 
Product Pipeline:  http://cellceutix.com/pipeline/

http://cellceutix.com/wp-content/uploads/2015/06/Cellceutix-Fact-Sheet-June-2015-flattened-1.pdf

 
Recent News and Press Releases: 
http://finance.yahoo.com/q/h?s=CTIX+Headlines

Seeking Alpha focus articles on CTIX: http://seekingalpha.com/symbol/CTIX
 
http://cellceutix.com/category/press-release/

A randomized, double-blind study comparing single-dose and short-course brilacidin to daptomycin in the treatment of acute bacterial skin & skin structure infections (ABSSSI)

http://eccmid.meetingexpert.net/ECCMID_546/poster_122533/program.aspx/anchor122533

Synthetic novel host defense protein mimetics for the treatment of Gram-negative bacterial infections

http://eccmid.meetingexpert.net/ECCMID_546/poster_122353/program.aspx

 
SEC Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=Cellceutix+Corp&match=&CIK=ctix&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f
cs@wcsti.com
http://www.westcoaststocktransfer.com/

 
Share Structure:  See SEC filing link above for current share structure
 

Cellceutix IP - Patent Filings:
EPO
http://worldwide.espacenet.com/searchResults?PA=Cellceutix&DB=EPODOC&locale=en_EP&ST=advanced&compact=false
WIPO
http://www.wipo.int/patentscope/search/en/detail.jsf?docId=WO2010135170&recNum=1&docAn=US2010034838&queryString=FP:(Cellceutix)&maxRec=1
USPTO
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=Cellceutix&FIELD1=AS&co1=AND&TERM2=&FIELD2=&d=PG01 


http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,796,275.PN.&OS=PN/8,796,275&RS=PN/8,796,275
 

Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
 
External Links: USPTO, USPTO Assignment, Espacenet


http://www.google.com/patents/US8338454

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=6&f=G&l=50&co1=AND&d=PG01&s1=Cellceutix.AS.&OS=AN/Cellceutix&RS=AN/Cellceutix

 
Investor Relations:  info@cellceutix.com

Following is a WEEKLY chart:


 
 

 
 
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTIX
Current Price
Volume:
Bid Ask Day's Range
Wiki
CTIX News: Special Profile Coming and 4 Analyst Reports 07/21/2015 07:00:00 AM
CTIX News: Undervalued and Underexposed NYSE-MKT Stock to be Profiled by Large Media Group and four brief reports 06/15/2015 07:00:00 AM
CTIX News: Special Profile & Four Companies Where Investors are Anticipating Success 06/03/2015 07:00:00 AM
CTIX News: *Special Analyst Alert* and 4 Companies that are Worth a Look 05/13/2015 07:00:00 AM
CTIX News: Quarterly Report (10-q) 05/11/2015 02:03:16 PM
PostSubject
#120460  Sticky Note Cellceutix’s Prurisol: A Potential Blockbuster Psoriasis Treatment TOB 08/28/15 03:20:01 PM
#119441  Sticky Note Cellceutix's Clinical Trial of Anti-Cancer Agent Kevetrin Meeting starbuxsux 08/20/15 03:41:27 PM
#118370  Sticky Note SHAREHOLDER VISITS TO CELLCEUTIX... BooDog 08/15/15 09:47:45 PM
#118219  Sticky Note $CTIX - My visit to Cellceutix, the biotech KarinCA 08/14/15 02:19:08 PM
#117849  Sticky Note The topic to be discussed here is CTIX. IH Admin [Dan] 08/12/15 12:28:39 PM
#117003  Sticky Note Cellceutix released efficacy data for Kevetrin, its cancer TOB 08/09/15 03:05:24 PM
#120552   Soon ctix shareholders bungle in the jungle! scottsmith 08/30/15 05:30:42 PM
#120551   TD I predict a green close tomorrow, and Matagordaville 08/30/15 05:11:27 PM
#120550   We own the equalizer. Aka Rally Monkey. Bank Matagordaville 08/30/15 05:00:35 PM
#120549   So in plain ENGLISH he and his opinions NotRichYet2 08/30/15 04:18:31 PM
#120548   They are not the smart money. Look at SJ2013 08/30/15 03:57:47 PM
#120547   ALL? We're talkin regeneron numbers. After believer20 08/30/15 03:30:26 PM
#120546   A poster mentioned Vegas...leo makes this thing look believer20 08/30/15 03:26:41 PM
#120545   all WILL BE SUCCESSUFL, if so, I suspect JUST 10-11-12 08/30/15 03:20:06 PM
#120544   Brilacidin will be approved. I believe this Phase DesireToLearn 08/30/15 03:06:21 PM
#120543   HOW CAN THEY BE THE SMART MONEY?????????? NotRichYet2 08/30/15 03:03:18 PM
#120541   thank you, thank you eom gov govorchin 08/30/15 02:45:32 PM
#120540   Well, it looks like the votes are in. etradeedge 08/30/15 02:39:40 PM
#120539   Yes indeed, words of wisdom.. TimetoRetire 08/30/15 01:20:14 PM
#120538   Pretty great odds when you can invest, lets TimetoRetire 08/30/15 01:16:01 PM
#120537   Two of the most powerful warriors are patience TheHound 08/30/15 01:09:57 PM
#120536   Outstanding, super well-informed post. You explained the design biodoc 08/30/15 01:08:53 PM
#120535   We could fail in 75% of trials and TimetoRetire 08/30/15 12:59:15 PM
#120534  Restored I agree...you definitely need to sell short. It TheHound 08/30/15 12:34:34 PM
#120528   Calendar of Independent Ethics Committee of the University romaa 08/30/15 06:50:31 AM
#120527   My ctix target eoy $7 to $12. Eom BooDog 08/30/15 12:50:52 AM
#120526   Sharvey says 10 cents from a 4.40 Sell etradeedge 08/29/15 11:18:14 PM
#120525   You too , now for some football BobbyKIrk 08/29/15 06:51:41 PM
#120524   Sounds great! I know how you feel. Trust TheHound 08/29/15 06:40:54 PM
#120523   I was getting to the point to sell BobbyKIrk 08/29/15 06:37:47 PM
#120522   See below. He still owns several hundred thousand TheHound 08/29/15 05:02:17 PM
#120521   60,000 at 1.60 I hope he doesn't regret BobbyKIrk 08/29/15 04:22:04 PM
#120520   Thanks. I had no reason to lie about TheHound 08/29/15 03:51:58 PM
#120519   Hound ,you were right I was just busting BobbyKIrk 08/29/15 01:52:31 PM
#120516   lmao. I totally get what you are saying TheHound 08/29/15 11:54:24 AM
#120515   Lol. I'm just glad he and timetoretire scottsmith 08/29/15 11:48:00 AM
#120514   I knew that 60k sell back on 8/20 TheHound 08/29/15 11:44:45 AM
#120513   It is amazing that less than half of thefamilyman 08/29/15 11:27:52 AM
#120512   I agree with Karin when she said "The TheHound 08/29/15 11:15:21 AM
#120511   Okay. Joke's on me then. :-D ctix 08/29/15 11:03:23 AM
#120510   fan-tas-tic noretreat 08/29/15 10:52:57 AM
#120509   Not a very useful measure, and easily misused. noretreat 08/29/15 10:50:02 AM
#120508   thanks ctix i think they are just govorchin 08/29/15 10:46:19 AM
#120507   Thanks...that certainly boosts my view on the probability noretreat 08/29/15 10:42:09 AM
#120505   I shared your concern on that primary outcome. frrol 08/29/15 10:37:20 AM
#120504   TD, gov's link worked for me. If ctix 08/29/15 10:01:12 AM
#120502   no it is about a treatment for ovarian govorchin 08/29/15 09:30:36 AM
#120501   Yes. Elsewhere. I think the F1ash 08/29/15 09:13:10 AM
#120496   FINRA short sales of CTIX = MISLEADING DATA NanoEngineer 08/29/15 08:34:14 AM
#120495   my daughter sent me the following govorchin 08/29/15 08:33:31 AM
#120493   Of course they are. All the short sales loanranger 08/29/15 08:05:11 AM
#120492   Why would the results of the Phase 2 loanranger 08/29/15 07:25:53 AM
#120490   R ur numbers the same as this? http://otcshortreport.com/index.php?index=CTIX&a Amatuer17 08/29/15 07:00:31 AM
#120489   Another keeper. Thanks a lot for putting it sox040713 08/29/15 01:41:29 AM
#120488   An explanation of Finra's daily short volume. nishimark 08/28/15 11:37:26 PM
#120487   Yes sir.. we have similar stories. I really TimetoRetire 08/28/15 10:51:24 PM
PostSubject